ID: ALA3888345
Type: Binding
Description: Kinase Activity Assay: The kinase reaction buffer consists of 50 mM Tris pH 8.5, 0.01% BRIJ-35, 10 mM MgCl2, 1 mM EGTA, and 2 mM DTT. In the assay, 1 nM LRRK2 WT or 250 pM LRRK2 G2019S kinase is incubated with the test compound (typically at 0 to 30 μM) for 30 minutes before the kinase reaction is initiated by addition of 1.3 mM ATP and 0.4 μM fluorescein-LRRKtide. The reaction mixture (20 μl total volume) is incubated for 2 hours at 30 °C. before the reaction is terminated by addition of 10 mM EDTA and 1 nM terbium-labelled anti-phospho-LRRKtide antibody (final volume 20 μl). The mixture is further incubated for 30 minutes at RT. TR-FRET is measured by excitation of the terbium-donor with 340 nm light and subsequent (delay time 100 μs) measurement of terbium and fluorescein emission at 495 nm and 520 nm, respectively, over a time window of 1000 μs. The measurement is repeated 10 times for fluorescein and 10 times for terbium emission with a 2000 μs time window between repeats. TR-FRET measurements are performed on a Biomek Synergy plate. The TR-FRET signal is calculated as the emission-ratio at 520 nm over 495 nm.
Bioactivity
Activity Types for Assay ALA3888345
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
392.46 | 2.64 | 2.64 |
412.93 | 3.66 | 3.66 |
396.47 | 3.14 | 3.14 |
377.45 | 3.09 | 3.09 |
426.91 | 3.30 | 3.30 |
378.48 | 3.00 | 3.00 |
377.45 | 3.09 | 3.09 |
364.45 | 3.01 | 3.01 |
334.43 | 3.16 | 3.16 |
426.91 | 3.30 | 3.30 |
376.46 | 2.84 | 2.84 |
333.40 | 3.25 | 3.25 |
392.46 | 2.64 | 2.64 |
319.37 | 3.99 | 3.99 |
422.49 | 2.65 | 2.65 |
392.51 | 3.31 | 3.31 |
332.41 | 3.66 | 3.66 |
335.42 | 2.56 | 2.56 |
351.41 | 2.86 | 2.86 |
365.44 | 3.20 | 3.20 |
408.51 | 3.01 | 3.01 |
349.44 | 3.50 | 3.50 |
412.93 | 3.66 | 3.66 |
317.35 | 3.74 | 3.74 |
406.49 | 2.57 | 2.57 |
378.48 | 3.00 | 3.00 |
406.49 | 2.95 | 2.95 |
392.51 | 3.04 | 3.04 |
410.45 | 2.78 | 2.78 |
396.47 | 3.14 | 3.14 |